Aktive Positionen von Dale E. Johnson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Emiliem, Inc.
 Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 11.03.2010 | - | |
| Gründer | - | - | |
| Präsident | 11.03.2010 | - |
Karriereverlauf von Dale E. Johnson
Ehemalige bekannte Positionen von Dale E. Johnson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Dale E. Johnson
| University of Michigan | Doctorate Degree |
| University of Michigan College of Pharmacy | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Health Technology |
- Börse
- Insiders
- Dale E. Johnson
- Erfahrung
